Elena Andreucci

Florence, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

Selective Nanomolar Inhibitors of Carbonic Anhydrases IX and XII: Coumarin Aminophosphonates as Potential Anticancer Agents.

Selective Nanomolar Inhibitors of Carbonic Anhydrases IX and XII: Coumarin Aminophosphonates as Potential Anticancer Agents.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: February 11, 2026

Die hard: when cells refuse apoptosis-the rise of paraptosis and other death pathways.

Die hard: when cells refuse apoptosis-the rise of paraptosis and other death pathways.

Journal: Cell death discovery

Published: January 21, 2026

Ketoconazole-carbonic anhydrase inhibitors as potential anticancer agents.

Ketoconazole-carbonic anhydrase inhibitors as potential anticancer agents.

Journal: European journal of medicinal chemistry

Published: November 06, 2025

Discovery of First-in-Class Carbonic Anhydrase/Histone Deacetylase Dual Inhibitors with Antiproliferative Activity in Cancer Cells.

Discovery of First-in-Class Carbonic Anhydrase/Histone Deacetylase Dual Inhibitors with Antiproliferative Activity in Cancer Cells.

Journal: Journal of medicinal chemistry

Published: October 28, 2025

Domain-specific phenotypic profiles in RAF1-related Noonan syndrome.

Domain-specific phenotypic profiles in RAF1-related Noonan syndrome.

Journal: European journal of human genetics : EJHG

Published: September 23, 2025

Unraveling the Potential of Amino‑, Acylamino‑, and Ureido-Substituted 3H‑1,2-Benzoxaphosphepine 2‑Oxides toward Nanomolar Inhibitors of Tumor-Associated Carbonic Anhydrases IX and XII.

Unraveling the Potential of Amino‑, Acylamino‑, and Ureido-Substituted 3H‑1,2-Benzoxaphosphepine 2‑Oxides toward Nanomolar Inhibitors of Tumor-Associated Carbonic Anhydrases IX and XII.

Journal: ACS medicinal chemistry letters

Published: February 24, 2025

Skin Telocyte Secretome as Conditioned Medium Prevents Profibrotic Differentiation of Skin Fibroblasts into Myofibroblasts.

Skin Telocyte Secretome as Conditioned Medium Prevents Profibrotic Differentiation of Skin Fibroblasts into Myofibroblasts.

Journal: International journal of molecular sciences

Published: December 18, 2024

Editorial: Turning cold tumors hot: insights into molecular mechanisms and clinical applications of immunogenic cell death.

Editorial: Turning cold tumors hot: insights into molecular mechanisms and clinical applications of immunogenic cell death.

Journal: Frontiers in cell and developmental biology

Published: September 13, 2024

Acidity and hypoxia of tumor microenvironment, a positive interplay in extracellular vesicle release by tumor cells.

Acidity and hypoxia of tumor microenvironment, a positive interplay in extracellular vesicle release by tumor cells.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: June 28, 2024

Blockade of Sialylation with Decrease in Polysialic Acid Levels Counteracts Transforming Growth Factor β1-Induced Skin Fibroblast-to-Myofibroblast Transition.

Blockade of Sialylation with Decrease in Polysialic Acid Levels Counteracts Transforming Growth Factor β1-Induced Skin Fibroblast-to-Myofibroblast Transition.

Journal: Cells

Published: May 23, 2024

The critical role of glutamine and fatty acids in the metabolic reprogramming of anoikis-resistant melanoma cells.

The critical role of glutamine and fatty acids in the metabolic reprogramming of anoikis-resistant melanoma cells.

Journal: Frontiers in pharmacology

Published: April 23, 2024

Expanding the molecular landscape of childhood apraxia of speech: evidence from a single-center experience.

Expanding the molecular landscape of childhood apraxia of speech: evidence from a single-center experience.

Journal: Frontiers in neuroscience

Published: March 05, 2024

Showing 1-12 of 64

Last Updated: 09/26/2026